Referred to the House Committee on the Judiciary.
This bill would repeal key parts of the 2011 Leahy‑Smith America Invents Act and change U.S. patent law to strengthen patent owners’ rights. Major changes include returning to a first‑to‑invent system (including a one‑year grace period), abolishing inter partes and post‑grant review and the Patent Trial and Appeal Board (reinstating the older Board of Patent Appeals and Interferences), expanding patentable subject matter (including many scientific discoveries and software), restoring and strengthening presumptions of validity and injunctive relief, ending automatic 18‑month publication of applications, reinstating the best‑mode requirement, and creating a revolving USPTO fund to prevent fee diversion.
Liberals emphasize risks to access, competition, and downstream research from broader patentability and stronger enforcement; conservatives emphasize property rights, judicial primacy, and reduced agency power.
Relative to its intended legislative type, this bill is a substantive policy overhaul of the U.S. patent system with considerable specificity in statutory amendments, but with notable gaps in implementation sequencing, transitional provisions, edge-case handling, and oversight.
This bill would repeal key parts of the 2011 Leahy‑Smith America Invents Act and change U.S. patent law to strengthen patent owners’ rights.
Major changes include returning to a first‑to‑invent system (including a one‑year grace period), abolishing inter partes and post‑grant review and the Patent Trial and Appeal Board (reinstating the older Board of Patent Appeals and Interferences), expanding patentable subject matter (including many scientific discoveries and software), restoring and strengthening presumptions of validity and injunctive relief, ending automatic 18‑month publication of applications, reinstating the best‑mode requirement, and creating a revolving USPTO fund to prevent fee diversion.
The bill emphasizes that patents are private property revocable only by courts and shifts burdens and procedures toward judicial resolution of validity disputes.
Judged solely on content and typical legislative dynamics, this is a policy‑heavy, comprehensive rollback of a major 2011 reform and several key judicial interpretations. Such sweeping, technical, and stakeholder‑sensitive changes usually require long negotiation, coalition‑building across industries with conflicting interests, and likely compromise. The absence of built‑in compromise features and the presence of highly contentious provisions reduce the chance of the bill emerging intact as law; parts could advance if substantially narrowed or incorporated into a larger, negotiated package.
Relative to its intended legislative type, this bill is a substantive policy overhaul of the U.S. patent system with considerable specificity in statutory amendments, but with notable gaps in implementation sequencing, transitional provisions, edge-case handling, and oversight.
Liberals emphasize risks to access, competition, and downstream research from broader patentability and stronger enforcement; conservatives emphasize property rights, judicial primacy, and reduced agency power.
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals emphasize risks to access, competition, and downstream research from broader patentability and stronger enforcement; conservatives emphasize property rights, judicial primacy, and reduced agency power.
A mainstream liberal observer would likely view this bill skeptically.
The bill significantly strengthens patentees’ enforcement power and eliminates administrative review routes that currently provide relatively quick and lower‑cost challenges to weak or overly broad patents, which could increase monopolistic control over medicines, seeds, software, and other critical inputs.
They would be concerned that broader patentability (including many life‑science discoveries and software) plus presumptions of validity and a presumption favoring injunctions will raise prices, slow downstream research, and empower patent assertion entities.
A pragmatic centrist would see both positives and negatives in this bill.
They would welcome clearer property‑rights language, restored USPTO funding, and certain predictability gains for inventors and investors, but worry about creating incentives for increased litigation, longer monopolies, and unintended effects on consumer prices.
Centrists would focus on the tradeoffs between stronger patent enforcement and the economic costs of limiting competition and follow‑on innovation.
A mainstream conservative observer inclined toward property rights and limited agency power would generally view this bill favorably.
It restores strong private‑property framing of patents, shifts final authority over patent validity to courts, curbs administrative adjudication (abolishing PTAB and IPR), and prevents fee diversion from the USPTO — all consistent with limiting executive/agency discretion and protecting individual rights.
The expansion of patentable subject matter and presumption of injunctions align with protecting inventors’ ability to exclude others.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Judged solely on content and typical legislative dynamics, this is a policy‑heavy, comprehensive rollback of a major 2011 reform and several key judicial interpretations. Such sweeping, technical, and stakeholder‑sensitive changes usually require long negotiation, coalition‑building across industries with conflicting interests, and likely compromise. The absence of built‑in compromise features and the presence of highly contentious provisions reduce the chance of the bill emerging intact as law; parts could advance if substantially narrowed or incorporated into a larger, negotiated package.
The bill has not accumulated any surfaced votes yet.
Liberals emphasize risks to access, competition, and downstream research from broader patentability and stronger enforcement; conservatives…
Judged solely on content and typical legislative dynamics, this is a policy‑heavy, comprehensive rollback of a major 2011 reform and severa…
Relative to its intended legislative type, this bill is a substantive policy overhaul of the U.S. patent system with considerable specificity in statutory amendments, but with notable gaps in implementation sequencing,…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.